Ruthigen, Inc., , a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company has submitted an Investigational New Drug Application to the U.S. Food and Drug Administration for its lead drug candidate ... (more)
More...
More...